Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lusine Harutyunyan
Observed name:
Lusine HARUTYUNYAN
Institutions:
Armenian State University of Economics,
Ministry of Healthcare
Observed institutions:
Vardhman Mahavir Medical College & Safdarjung Hospital,
Armenian State University of Economics,
Istituto Superiore di Sanità,
Tata Memorial Hospital,
Ministry of Healthcare,
Clínica Ruiz,
Yerevan State Medical University
show all 7
ORCID:
0000-0002-3499-4862
Observed ORCIDs:
0000-0002-3499-4862,
0009-0000-6983-8870
OpenAlex ID:
A5059745530
Identification of Hedging Strategies in Business Negotiations
2022
·
Lusine HARUTYUNYAN
, Ruzanna BAGHRAMYAN
·
wisdom
·
4
The Experience of Hematologic Oncology in Armenia
2024
·
Alisa Movsisyan
, Liana Hambardzumyan
, et al.
·
OncoDaily Medical Journal
·
2
PDF
CML-307: Assessment of 5-Year OS and Treatment Options in Newly Diagnosed Ph + CML Patients in the Republic of Armenia
2021
·
Lusine Harutyunyan
, Astghik Voskanyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
CML-218: Primary Diagnosed CML Patient 5-Year Treatment Outcomes and Disease Incidence in an Armenian Population
2020
·
Lusine Harutyunyan
, Karen Meliksetyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) international registry: Assessment of the allo-HCT outcomes
2025
·
Lusine Harutyunyan
, Marina Konopleva
, et al.
·
Blood
·
1
CT-118: Systemic Mastocytosis in Armenia: A Rare Disease With Two Documented Cases
2025
·
Lusine Harutyunyan
, Alvard Poghosyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Tolerability and safety of a new oral device for prevention and treatment of oral mucositis in patients with hematologic malignancies undergoing chemotherapy
2025
·
Artem Oganesyan
, Lusine Harutyunyan
, et al.
·
Supportive Care in Cancer
·
1
PDF
423 Treatment of relapsed and refractory lymphomas with nivolumab in a limited recourse country
2022
·
Lusine Harutyunyan
, Anahit Ter-Grigoryan
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
HL-367 ASCT for Treatment-Resistant Mediastinal Gray Zone Lymphoma
2022
·
Artem Oganesyan
, Nerses Ghahramanyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Poster: CML-187 Association of Molecular Remission With Eutos and ELTS Risk Scores Among CML Patients in the Armenian Cohort
2022
·
Lusine Harutyunyan
, Arusyak Ivanyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
ABCL-258 Incidence Patterns of Non-Hodgkin Lymphoma in the Republic of Armenia
2022
·
Lusine Sahakyan
, Lusine Harutyunyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Challenges of management and outcomes of multiple myeloma in Armenia: A real world experience from a developing country
2026
·
Nerses Ghahramanyan
, Samvel Bardakhchyan
, et al.
·
Blood Global Hematology
PDF
173Multimodal Approach to Business Pitch Assessment Experimented at the Armenian State University of Economics
2026
·
Lusine Harutyunyan
, Susanna Chalabyan
, et al.
·
De Gruyter eBooks
PB2337 Congenital Thrombotic Thrombocytopenic Purpura with Chronic Kidney Disease in a Pediatric Patient: A Rare and Prolonged Clinical Course
2026
·
Hermine Sayiyan
, Elen Avetisyan
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PDF
PB3539 A Unique Case of Coexisting von Willebrand Disease, β-Thalassemia Minor, MEFV Mutation, and Severe Platelet Aggregation Defect in a Pediatric Patient
2026
·
Heghine Khachatryan
, Samvel Avetisyan
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PB3441 Challenges in Diagnoses and Disease Burden Evaluation of von Willebrand Disease in a LMIC: A Four-Decade Retrospective Cohort from Armenia’s National Registry
2026
·
Kristian Simonyan
, Anna Movsisyan
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PDF
ALL-1532: Incidence of CRK and MRSA From Blood and Urine Samples of Onco-Hematological Patients in Armenia
2026
·
Diana Soghomonyan
, Marieta Meliksetyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: ALL-1532: Incidence of CRK and MRSA From Blood and Urine Samples of Onco-Hematological Patients in Armenia
2026
·
Diana Soghomonyan
, Marieta Meliksetyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials
2026
·
Artem Oganesyan
, Andrew Gregory
, et al.
·
Frontiers in Oncology
PDF
Financial toxicity-associated nivolumab dose modifications in lymphoma patients: Real-world cohort from Armenia
2026
·
Lusine Harutyunyan
, Nerses Ghahramanyan
, et al.
·
Cancer Plus
PDF
POSTER: ABCL-549 Five-Year Experience With Burkitt Lymphoma: Trends and Outcomes From a Single-Center Cohort in Armenia
2025
·
Hasmik Oseyan
, Lusine Harutyunyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-118 Systemic Mastocytosis in Armenia: A Rare Disease With Two Documented Cases
2025
·
Lusine Harutyunyan
, Alvard Poghosyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ABCL-549: Five-Year Experience With Burkitt Lymphoma: Trends and Outcomes From a Single-Center Cohort in Armenia
2025
·
Hasmik Oseyan
, Lusine Harutyunyan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Understanding the causes of high mortality among adult acute leukaemia patients in Armenia
2025
·
Astghik Voskanyan
, Lusine Harutyunyan
, et al.
·
ecancermedicalscience
PDF
666 Prevalence and management of orofacial side effects in patients receiving immunotherapy in armenia: a multicenter prospective study
2024
·
Lusine Harutyunyan
, Karine Soghomonyan
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
44
Citation count:
17
H-index:
2
I10-index:
Year
Topic
Type